The Centers for Medicare and Medicaid Services issued a proposed decision that states there is not enough evidence to support screening coverage of computed tomography colonography for colorectal cancel.

In its proposed Decision Memo for Screening released on Wednesday, Feb. 11, CMS encouraged the public to comment on the noncoverage determination as well as the cost effectiveness of CT colonography screening for the Medicare population. The comment period lasts for 30 days.

This announcement follows the recommendations of a CMS panel that convened in November. The majority of panelists, who assessed the evidence for and against VC screening, believed there was insufficient evidence supporting virtual colonography as a cost-effective tool.

“As with all national coverage analyses, the public may submit comments or additional evidence that cause us to reassess our evidentiary review and arrive at different conclusions,” according to the report.

To read the complete proposed Decision Memo, click here